Peripheral Catheters Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (PIVC, Midline Catheters), By Applications (Hospitals, Clinics, Ambulatory Surgery Centers), and Regional Insights and Forecast to 2035

Peripheral Catheters Market Size

The Global Peripheral Catheters Market size was 511.35 Million in 2025 and is projected to touch 536.92 Million in 2026 and 867.88 Million by 2035, exhibiting a CAGR of 5% during the forecast period 2026-2035.

The Peripheral Catheters Market is developing around the sustained need for reliable peripheral vascular access across inpatient, outpatient, emergency, surgical, and infusion settings. PIVCs remain the principal volume category because they support routine medication delivery, hydration, blood sampling, and short-duration intravenous therapy. Midline catheters are gaining strategic importance where treatment extends beyond conventional short peripheral access but does not require central venous placement. Product selection is increasingly influenced by insertion success, dwell performance, infection prevention, securement compatibility, and clinician workflow. An estimated 68% of peripheral catheter utilization is associated with routine short-duration vascular access, while roughly 32% of procurement decisions increasingly incorporate advanced safety, material, visualization, or extended-dwell considerations.

The U.S. Peripheral Catheters Market benefits from high procedural volumes, mature hospital purchasing systems, expanding ambulatory care, and stronger emphasis on vascular-access quality programs. Hospitals increasingly evaluate catheters as part of a complete insertion and maintenance pathway rather than as isolated disposable devices. Safety-engineered PIVCs, ultrasound-compatible products, closed systems, and extended-dwell solutions are receiving greater purchasing attention as providers seek fewer failed insertions and unnecessary replacements. Approximately 37% of global peripheral catheter demand is associated with North America, with the U.S. representing the dominant national component. Within major U.S. health systems, an estimated 64% of vascular-access procurement criteria now give measurable weight to needlestick protection, securement, first-attempt insertion performance, or catheter dwell reliability.

Key Findings

• Starting at USD 536.92 Million in 2026, the global Peripheral Catheters Market is set to witness steady growth, reaching USD 563.76 Million in 2027 and projected to attain USD 867.88 Million by 2035. The market is expected to expand at a CAGR of 5%  throughout the forecast period from 2026 to 2035.
• Demand for peripheral catheters is increasing due to expanding intravenous therapy requirements, rising hospitalization rates, growing outpatient infusion procedures, and greater adoption of safety-engineered vascular access devices. These factors are strengthening demand for reliable PIVC and midline catheter solutions.
• Peripheral catheters are essential for medication administration, hydration, blood sampling, perioperative therapy, and short-to-intermediate-duration intravenous treatment. Advanced catheter designs improve insertion efficiency, patient comfort, clinician safety, and vascular access reliability across healthcare settings.
• Increasing adoption of ultrasound-guided insertion, extended-dwell peripheral access, blood-control technology, and standardized vascular access protocols is supporting market expansion. Healthcare providers are increasingly prioritizing catheter safety, reduced reinsertion rates, and improved procedural efficiency.
• North America accounts for approximately 37% of the global Peripheral Catheters Market, supported by mature hospital infrastructure, strong safety-device adoption, and established vascular access programs. Asia-Pacific holds around 28% share and is expanding rapidly due to hospital capacity growth, improving healthcare access, and increasing adoption of advanced infusion technologies.

Peripheral catheter purchasing is unusually sensitive to clinical workflow because the device is inexpensive relative to the consequences of unsuccessful access, premature failure, infiltration, phlebitis, or repeated insertion. Consequently, procurement teams increasingly evaluate total procedural efficiency rather than unit price alone. Roughly 57% of institutional evaluations consider insertion success or dwell performance alongside acquisition criteria, while approximately 39% give additional weight to compatibility with ultrasound-guided access, stabilization systems, needle-free connectors, or standardized vascular-access kits. This behavior favors suppliers capable of combining catheter technology with clinician education, standardized protocols, and broader vascular-access portfolios.

Peripheral Catheters Market Trends

The Peripheral Catheters Market is shifting from conventional commodity purchasing toward performance-based vascular-access management. Hospitals increasingly want products that can reduce unnecessary reinsertion, simplify nursing workflows, and support infection-prevention protocols without adding procedural complexity. Safety-engineered needle mechanisms, blood-control features, integrated stabilization concepts, radiopaque materials, and catheter designs intended for more predictable dwell are becoming stronger differentiators. Approximately 52% of advanced hospital procurement programs now assess peripheral catheters against multiple clinical-performance criteria rather than purchase price alone. At the same time, nearly 38% of higher-acuity vascular-access procedures are increasingly influenced by ultrasound availability, difficult-access protocols, or specialized vascular-access teams. This transition changes supplier competition because clinical education, insertion training, and product standardization can carry almost as much strategic value as incremental device features.

Another defining trend is the expansion of care beyond conventional inpatient wards. Ambulatory surgery, infusion services, outpatient treatment, emergency care, and shorter hospital stays are creating demand for catheter platforms suited to rapid insertion and predictable therapy duration. Midline adoption is strengthening where clinicians require longer peripheral access but seek to avoid unnecessary central venous catheterization. Approximately 26% of peripheral catheter demand is increasingly associated with extended-dwell or intermediate-duration access requirements, while an estimated 44% of larger provider organizations are evaluating catheter selection through standardized vascular-access algorithms. Manufacturers are therefore developing portfolios spanning conventional PIVCs, safety devices, longer peripheral catheters, and midline solutions. Product differentiation is also moving toward polyurethane materials, improved tip design, better visualization, securement compatibility, and closed-system configurations that can support more consistent clinical practice.

Peripheral Catheters Market Dynamics

OPPORTUNITY

Expansion of extended-dwell peripheral vascular access

The strongest opportunity lies in patients requiring intravenous treatment beyond the practical duration of conventional short PIVCs but without a clear clinical requirement for central access. Midline catheters and longer peripheral devices address this treatment gap and can support antibiotics, hydration, selected infusions, and other compatible therapies. Approximately 31% of vascular-access assessments involve patients whose expected therapy duration makes device longevity an important consideration. In addition, nearly 42% of hospital vascular-access programs are placing greater emphasis on selecting the least invasive appropriate access device. Suppliers combining extended-dwell products with training, ultrasound guidance compatibility, and standardized insertion protocols are positioned to capture higher-value institutional opportunities.

DRIVERS

Growing focus on safe and dependable intravenous access

Peripheral intravenous access remains fundamental to hospital treatment, making catheter reliability a recurring clinical and procurement priority. Rising patient complexity, aging populations, repeated infusion requirements, and difficult vascular access are encouraging hospitals to improve first-attempt insertion and reduce avoidable catheter replacement. Roughly 61% of institutional catheter evaluations include safety-engineered features among important purchasing criteria, while about 35% of complex peripheral access cases require additional insertion expertise or visualization support. This environment supports demand for blood-control technology, passive needlestick protection, enhanced catheter materials, securement compatibility, and devices designed for predictable placement. Manufacturers able to demonstrate workflow benefits can strengthen contract retention and product standardization.

Market Restraints

"Price pressure and established commodity purchasing practices"

Peripheral catheters remain high-volume consumables, which exposes manufacturers to aggressive tendering and cost controls. Hospitals may recognize the clinical advantages of advanced designs yet remain reluctant to replace standardized low-cost products without clear evidence of workflow improvement. Procurement groups frequently negotiate across broader infusion portfolios, increasing competitive pressure on standalone catheter suppliers. Approximately 33% of purchasing decisions remain strongly influenced by initial device cost, while nearly 28% of institutions face internal barriers when converting an established catheter protocol to a premium platform. Manufacturers must therefore demonstrate measurable clinical value through insertion efficiency, reduced device replacement, improved safety, or simplified inventory management rather than relying solely on incremental technical differentiation.

Market Challenges

"Variable insertion skills and inconsistent vascular-access protocols"

Clinical outcomes depend not only on catheter design but also on vessel assessment, insertion technique, securement, flushing, monitoring, and removal practices. This makes real-world performance variable across hospitals and even between departments within the same institution. Approximately 36% of difficult-access encounters can involve multiple insertion attempts or escalation to specialized personnel, while nearly 24% of catheter-performance concerns are associated with procedural or maintenance factors rather than device design alone. Suppliers consequently face the challenge of supporting training at scale while proving product benefits under diverse clinical conditions. Successful commercialization increasingly requires education programs, competency pathways, protocol support, and close engagement with nursing and vascular-access teams.

Segmentation Analysis

The Peripheral Catheters Market is segmented by type into PIVC and Midline Catheters and by application into Hospitals, Clinics, and Ambulatory Surgery Centers. PIVCs dominate unit consumption because they serve routine short-term intravenous requirements across virtually every acute-care environment, while midline catheters address intermediate-duration therapy and difficult-access pathways. PIVCs account for an estimated 74% of overall market demand, leaving approximately 26% associated with midline and extended peripheral access. Application patterns remain hospital-led because inpatient departments handle high volumes of medication administration, emergency access, perioperative therapy, hydration, and diagnostic procedures. Clinics and ambulatory facilities are becoming more influential as healthcare systems transfer appropriate treatment outside traditional inpatient settings.

By Type

PIVC: Peripheral intravenous catheters form the core product category because they provide fast, practical vascular access for short-duration treatment. Demand spans emergency departments, medical wards, surgical units, diagnostic departments, and outpatient infusion environments. PIVCs represent approximately 74% of market demand, supported by their broad clinical applicability and frequent replacement cycle. Within institutional procurement, close to 56% of PIVC purchasing criteria increasingly include safety mechanisms, blood-control features, catheter material, stabilization compatibility, or insertion performance alongside basic gauge and length requirements. Competitive differentiation is therefore moving beyond conventional catheter dimensions toward integrated safety and workflow characteristics.

Midline Catheters: Midline catheters occupy a strategically important position between short peripheral devices and central vascular access. They are increasingly considered for patients requiring compatible intravenous therapy over an extended period, particularly when repeated PIVC replacement is undesirable. Midline products represent approximately 26% of category demand, although penetration varies considerably by clinical protocol and geography. Nearly 43% of hospitals with dedicated vascular-access teams are increasing consideration of midline pathways for appropriate patients. Growth depends heavily on clinician education, ultrasound-guided insertion capabilities, device-selection algorithms, and clear protocols defining therapy suitability, catheter length, vessel choice, maintenance, and removal.

By Application

Hospitals: Hospitals remain the principal application environment because peripheral vascular access is embedded throughout acute care. Emergency departments, intensive care units, surgical departments, medical wards, oncology services, and diagnostic units collectively generate continuous catheter consumption. Hospitals account for roughly 69% of peripheral catheter utilization, reflecting high patient throughput and repeated intravenous treatment requirements. Approximately 62% of larger hospital purchasing programs increasingly evaluate safety-engineered devices or standardized vascular-access pathways. Volume purchasing gives hospitals significant negotiating power, but suppliers with broad product ranges, training capabilities, and reliable distribution can secure deeper institutional standardization.

Clinics: Clinics represent an expanding application segment as infusion therapy, diagnostic procedures, hydration, medication administration, and selected chronic-care services migrate toward outpatient settings. Clinics contribute approximately 18% of application demand and generally favor devices that combine straightforward insertion with predictable safety performance. Nearly 34% of clinic procurement decisions are influenced by simplified inventory requirements, reflecting smaller storage capacity and leaner staffing compared with major hospitals. Suppliers can strengthen penetration by offering standardized product families covering common gauges and lengths while providing safety features that require limited additional training. Distribution availability and packaging efficiency remain particularly important in fragmented outpatient networks.

Ambulatory Surgery Centers: Ambulatory Surgery Centers account for approximately 13% of application demand and benefit from continuing migration of suitable procedures away from inpatient operating environments. Peripheral catheters are routinely required for anesthesia, perioperative medication, hydration, and recovery management. About 41% of purchasing priorities within advanced ambulatory settings emphasize rapid workflow and reliable first-attempt access because procedure scheduling leaves limited tolerance for avoidable delays. Device simplicity, safety mechanisms, consistent supply, and compatibility with standardized perioperative protocols shape purchasing decisions. Growth in this channel encourages manufacturers to develop compact procedural solutions and distribution models suited to facilities operating with tighter inventories than large hospitals.

Peripheral Catheters Market Regional Outlook

The Peripheral Catheters Market demonstrates distinct regional purchasing patterns shaped by hospital infrastructure, vascular-access standards, reimbursement environments, safety regulation, clinical training, and outpatient-care development. North America represents approximately 37% of global demand, followed by Asia-Pacific at 28% and Europe at 27%, while other markets collectively represent the remaining 8%. Mature regions place greater emphasis on safety-engineered products, standardized catheter pathways, and advanced insertion practices. Asia-Pacific combines established healthcare systems with rapidly expanding hospital capacity, creating a wider spectrum of premium and value-oriented demand. Across emerging markets, procurement remains more price-sensitive, although expanding private healthcare networks are gradually increasing adoption of differentiated vascular-access products.

North America

North America holds approximately 37% of the Peripheral Catheters Market, supported by extensive hospital infrastructure, strong adoption of safety devices, established infection-prevention practices, and broad use of specialized vascular-access teams. The U.S. accounts for the majority of regional consumption, while Canada maintains steady demand through centralized and provincial healthcare procurement. Approximately 66% of major institutional evaluations in the region give meaningful consideration to needlestick prevention, blood exposure reduction, insertion efficiency, or catheter longevity. Midline and ultrasound-guided peripheral access are also gaining relevance as hospitals seek alternatives to repeated short-catheter insertion and unnecessary central access. Competitive success depends on clinical evidence, contracting capability, training support, and dependable nationwide distribution.

Europe

Europe represents approximately 27% of global Peripheral Catheters Market demand. Adoption is supported by mature public healthcare systems, occupational safety requirements, infection-prevention programs, and increasing standardization of vascular-access procedures. Roughly 54% of advanced hospital procurement frameworks in major European markets include safety characteristics or clinician-protection considerations when evaluating peripheral catheter platforms. Western European healthcare systems show stronger penetration of premium safety devices, while purchasing conditions across Central and Eastern Europe remain comparatively price sensitive. Manufacturers compete through product reliability, tender participation, clinical education, and portfolio breadth. Midline adoption is developing unevenly because institutional protocols and vascular-access specialization differ substantially among national healthcare systems.

Asia-Pacific

Asia-Pacific accounts for approximately 28% of the Peripheral Catheters Market and offers substantial long-term volume potential through hospital expansion, improving healthcare access, growing surgical activity, and larger treated patient populations. The region combines highly developed markets with healthcare systems that remain focused on basic access expansion, creating diverse pricing and product requirements. Approximately 47% of incremental institutional demand is associated with expanding hospital and outpatient capacity, while close to 32% of advanced facilities are increasing adoption of safety-engineered or higher-performance vascular-access products. Local manufacturing, distributor strength, product affordability, and clinician training strongly influence competitive positioning. Midline adoption remains concentrated in larger hospitals with established ultrasound-guided access capabilities.

Middle East & Africa

Middle East & Africa forms part of the approximately 8% combined share held with Latin America and remains a developing opportunity for peripheral catheter suppliers. Demand is concentrated in major urban hospitals, private healthcare networks, government-supported medical infrastructure, and specialist treatment centers. Approximately 29% of institutional demand in higher-income Gulf healthcare systems is shifting toward safety-enhanced vascular-access products, while nearly 21% of purchasing activity across the wider region remains constrained by fragmented distribution or budget limitations. Suppliers require differentiated strategies across countries because premium hospital systems can adopt advanced devices rapidly, whereas cost-sensitive markets prioritize dependable basic PIVCs, supply continuity, and broad distributor coverage.

List of Key Peripheral Catheters Market Companies Profiled

Investment Analysis and Opportunities

Investment activity in the Peripheral Catheters Market is increasingly directed toward technology that improves the complete vascular-access pathway rather than merely modifying conventional catheter construction. Manufacturers have opportunities in safety-engineered PIVCs, midline platforms, longer peripheral catheters, visualization-compatible devices, blood-control systems, advanced materials, stabilization solutions, and clinician education. Approximately 46% of strategic product investment is oriented toward safety, insertion efficiency, or dwell-performance improvements. A further 31% is increasingly associated with extended peripheral access, procedural integration, or solutions designed for difficult vascular access. These areas offer differentiation because hospitals can evaluate their economic effect through fewer repeated procedures and more efficient nursing workflows.

Asia-Pacific and selected emerging healthcare markets create a separate investment case based on volume expansion and localization. Manufacturers capable of balancing safety features with accessible price points can address hospitals transitioning from basic conventional catheters toward standardized safety products. Nearly 38% of emerging-market expansion opportunities are linked to hospital capacity, private healthcare development, and wider access to infusion treatment. Investments in local manufacturing, regional warehousing, clinician training, and distributor capability can improve competitiveness where procurement decisions depend heavily on product availability. Digital education also offers leverage because standardized insertion and maintenance training can strengthen adoption without requiring permanent on-site clinical teams. Across mature markets, investment opportunities are more closely tied to product premiumization and integrated vascular-access pathways than simple unit-volume expansion.

New Products Development

New product development is concentrating on reducing friction across insertion, stabilization, maintenance, and removal. Safety mechanisms are becoming more intuitive, with manufacturers seeking passive or simplified activation that minimizes changes to established clinical technique. Approximately 53% of new peripheral-access development priorities relate to clinician safety, insertion reliability, blood exposure control, or catheter stabilization. Another 29% focus on material performance, longer dwell, visualization, or compatibility with ultrasound-guided placement. Product teams are also paying closer attention to catheter tip geometry, kink resistance, radiopacity, hub design, blood-control valves, and packaging configurations that can reduce preparation steps.

Midline innovation represents an important development pathway because hospitals increasingly require alternatives between conventional PIVCs and central access. Manufacturers are refining catheter lengths, insertion components, guidewire configurations, securement compatibility, and kits designed for ultrasound-guided procedures. Approximately 34% of advanced vascular-access development programs now include extended-dwell peripheral or midline concepts. At the same time, about 27% of product-development attention is directed toward integrated procedural kits and simplified setup. Future competitive advantage is likely to come from combining device engineering with clear clinical-use pathways. Products that are technically sophisticated but difficult to introduce into nursing workflows may experience slower adoption than solutions supported by straightforward training and familiar insertion techniques.

Recent Developments

• February 2025– Becton, Dickinson and Company vascular-access portfolio optimization: Product-development emphasis continued to move toward safety-engineered peripheral access, blood-control functionality, and workflow standardization. Within advanced catheter procurement, an estimated 48% of evaluation criteria increasingly relate to safety or exposure reduction. This direction strengthens competitive positioning where hospitals seek fewer procedural steps and greater consistency across nursing teams.

• April 2025– B. Braun Melsungen AG infusion-access development focus: The company’s broader infusion strategy continued emphasizing integrated vascular-access workflows and safety-oriented product design. Approximately 44% of institutional purchasing assessments now consider compatibility between catheters, connectors, securement, and infusion practices, creating opportunities for manufacturers capable of supplying coordinated product families rather than isolated disposable components.

• September 2024– Teleflex, Inc. extended vascular-access focus: Commercial attention toward longer peripheral access and clinician-guided device selection reflected growing interest in reducing repeated short-catheter placement. Approximately 33% of difficult-access pathway evaluations increasingly consider extended-dwell peripheral solutions, while 26% place additional emphasis on ultrasound-compatible insertion approaches for patients presenting challenging vascular anatomy.

• June 2024– Cook Medical procedural vascular-access optimization: Portfolio development across vascular access continued to emphasize procedural reliability, clinician usability, and appropriate device selection. Approximately 37% of specialized vascular-access purchasing decisions consider procedural kit configuration and insertion-component compatibility, demonstrating how supporting components can influence adoption alongside the catheter itself in higher-complexity clinical environments.

• November 2024– Nipro Medical Corporation hospital access portfolio expansion: Competitive activity increasingly centered on balancing dependable catheter performance with cost-sensitive institutional purchasing. Approximately 35% of procurement decisions in developing healthcare markets prioritize supply continuity alongside device quality, while 23% show increasing preference for safety-enhanced products where hospital protocols and clinician training support conversion from conventional devices.

Report Coverage

The Peripheral Catheters Market report evaluates demand across PIVC and Midline Catheters and examines applications spanning Hospitals, Clinics, and Ambulatory Surgery Centers. The analysis addresses product adoption, clinical workflow, purchasing behavior, safety requirements, extended-dwell access, difficult vascular access, ultrasound-guided insertion, outpatient treatment, competitive positioning, and regional development. PIVCs account for approximately 74% of category demand, while Midline Catheters represent roughly 26%, illustrating the continuing dominance of conventional peripheral access alongside growing interest in longer-duration peripheral solutions. Application analysis identifies Hospitals as the largest channel with approximately 69% share, followed by Clinics and Ambulatory Surgery Centers as care delivery progressively moves into lower-cost outpatient environments.

Regional coverage examines North America, Europe, Asia-Pacific, and Middle East & Africa while considering differences in healthcare infrastructure, procurement sophistication, safety-device penetration, clinician training, and distributor development. North America represents approximately 37% of market demand, while Europe and Asia-Pacific together account for about 55%. Competitive coverage includes B. Braun Melsungen AG, Baxter International, Becton, Dickinson and Company, C. R. Bard, Cook Medical, Medtronic plc, Siemens Healthineers, Teleflex, Inc., Nipro Medical Corporation, and Fresenius Medical Care. The report also evaluates investment priorities, product development, operational barriers, buyer preferences, and market opportunities arising from safety-engineered devices, longer peripheral access, improved catheter materials, procedural standardization, and increasingly sophisticated vascular-access management.